Valuation re-rating hinges on cyclical recovery in the core segment
Robust quarterly performance sets the stage for continued growth in H2
Strong business fundamentals and visibility of earnings growth justify the rich valuation
Growth rebound story at a reasonable valuation
Earnings are expected to taper off in the medium term due to intensifying market competition
The company plans to launch the injectable version of Semaglutide in a number of countries, starting with Canada in January 2026. India and Brazil will follow
Q2 shows modest improvement in operations while profitability and segmental performance remain variable
With the economy looking up, the bank seems ready to ride the upcycle
The company’s strong rebound in the FMEG business and outperformance in W&C continue
The government's move to cut GST on cement is a major uplift for infrastructure and real estate sectors. It will lower construction costs, generating strong demand for both new and existing projects
The CDMO business for small molecules grew 58 percent YoY in Q2FY26, helped by a ramp-up in sales from new manufacturing assets
Strategic growth levers, consumption boost will drive valuation
IGIL has a significant exposure to the American market and its stock valuation is attractive
Volume-led growth, moderating inflation will drive better profitability metrics
The bank is poised for a healthy loan growth and margin expansion, which should drive healthy earnings growth
The company aims to create an omni-channel consumer experience with a seamless customer journey across stores, websites, and online marketplaces
The company continues to invest in the semiconductor and battery chemicals businesses, and the next fiscal is expected to witness traction from these segments
Focus on affordable housing finance to continue; multiple strategic levers to lift valuations
Backward integration, improving wallet share, and new product development will be key growth drivers
Helped by the roadmap laid out by the new management, a steady but gradual improvement in the RoA is likely
The bank’s return ratios are healthy and the stock valuation is reasonable
Strong top-line growth driven by Blinkit, food delivery business steady on margins. Working capital intensity and profitability remain key watchpoints.
Multiple factors to support the premium valuation of the bank stock
In the long run, we believe that RIL should benefit from a tilt in Indian households’ spending mix towards premiumization and higher adoption of digitization
With 91 percent of the AUM coming from equity-oriented schemes, the AMC enjoys the highest share of equity assets among peers